PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer ; volume:31 ; number:4 ; day:17 ; month:4 ; year:2024 ; pages:539-551 ; date:7.2024
Breast cancer ; 31, Heft 4 (17.4.2024), 539-551, 7.2024
- Creator
-
Zhang, Huan-ping
Jiang, Rui-yuan
Zhu, Jia-yu
Sun, Ke-na
Huang, Yuan
Zhou, Huan-huan
Zheng, Ya-bing
Wang, Xiao-jia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12282-024-01567-5
- URN
-
urn:nbn:de:101:1-2409161038164.517803866984
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Huan-ping
- Jiang, Rui-yuan
- Zhu, Jia-yu
- Sun, Ke-na
- Huang, Yuan
- Zhou, Huan-huan
- Zheng, Ya-bing
- Wang, Xiao-jia
- SpringerLink (Online service)
Other Objects (12)
Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells
Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Linc00707 regulates autophagy and promotes the progression of triple negative breast cancer by activation of PI3K/AKT/mTOR pathway
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells
Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Linc00707 regulates autophagy and promotes the progression of triple negative breast cancer by activation of PI3K/AKT/mTOR pathway
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells
Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Linc00707 regulates autophagy and promotes the progression of triple negative breast cancer by activation of PI3K/AKT/mTOR pathway
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway